Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $5.0350 (-3.27%) ($4.3310 - $5.1200) on Wed. May. 27, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 9.85% (three month average) | RSI | 69 | Latest Price | $5.0350(-3.27%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.4% a day on average for past five trading days. | Weekly Trend | BCRX advances 6.3% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) UNG(5%) XLC(5%) IYT(4%) UUP(4%) VIXM(4%) | Factors Impacting BCRX price | BCRX will decline at least -4.925% in a week (0% probabilities). EWG(-5%) IBB(-4%) EWI(-4%) CEMB(-4%) XBI(-3%) | | | | | Relative Volatility | | | | Market Trend Strength | -4.925% (StdDev 9.85%) | Hourly BBV | -0.8 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $5.32(-5.36%) | 10 Day Moving Average | $5.2(-3.17%) | 20 Day Moving Average | $4.75(6%) | To recent high | -9.8% | To recent low | 0% | Market Cap | $888m | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |